rapid & real solution FOR YOUR CLIENTS
D'OXYVA® INTENDED USE
The recommended average starting dose of D’OXYVA® is 16g CO2 twice daily for 5 days per week for the first 2 weeks and once daily for 5 days per week for another 2 weeks. The average maintenance dose of D’OXYVA can be once a day for 3 days per week. The starting and maintenance dose of D’OXYVA should be individualized according to patient characteristics such as goals of therapy and response.
IMPORTANT SAFETY NOTICE: According to various human clinical trials with D’OXYVA, this product does NOT increase blood (PCO2) or tissue (TcPCO2) Carbon Dioxide (CO2) levels like anesthesia or other inhalation, needle injection or skin delivery CO2 medical gas delivery applications. It DOES improve blood (SpO2) and tissue (TcPO2) oxygen and pH balance. Increased CO2 levels in blood and tissue may be detrimental to some but increased O2 levels are typically beneficial.
D’OXYVA® (deoxyhemoglobin vasodilator) is becoming a standard setter in numerous fields and the first choice of doctors in a growing number of countries around the world for the solution of the most difficult complications caused by chronic diseases such as diabetes, cardiovascular, and various forms of cancer such as multiple myeloma.
D’OXYVA® (deoxyhemoglobin vasodilator) is the only fully non-invasive, non-irritating, non-opioid, and completely painless, skin delivery (over-the-skin) nerve stimulant and microcirculatory solution.
With over seven years of industry-leading research results, D’OXYVA® demonstrated that it does not break the skin’s barrier while it provides outsized quality of life and outcomes quickly and affordably.
In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D’OXYVA® is leading the field by:
✓ Significantly lowering the risk of diabetes and cardiovascular complications.
✓ Providing complete significant improvement of difficult wounds together with major pain relief and improved quality of life.
D’OXYVA®‘s gentle vapor solution with purified CO2 readily dissolves in a molecular form in the skin, acting as a catalyst to improve skin perfusion pressure and optimize nerve functions and microcirculation.
D’OXYVA® delivers fast solution to the areas you need it most. It’s also easy-to-use virtually anywhere — even from the comfort and privacy of your own home.
easy to use daily
How D'OXYVA Works?
For example, D’OXYVA® naturally delivers remarkable and fast pain management results without the use of opioids. In high-quality studies, it has demonstrated noticeable efficacy in the reduction and elimination of chronic pain — achieving over 90% elimination of all varieties of chronic pain in nearly all enrolled subjects the same day or in a few days.
D’OXYVA® (deoxyhemoglobin vasodilator) is a handheld applicator that’s the first biotech solution of its kind, underpinned by widely established, groundbreaking, Nobel Prize–winning science.
It’s been studied to significantly improve macro-, and micro-circulation of blood flow and certain nerve activities in the body, which is widely reported to boost fitness and form an effective noninvasive, pain-free solution for several widespread conditions.
✓ Inside the practice, at home or on the go, in 4-8 weeks with 5 minutes a day
Recommended & ranked top by experts!